The American Diabetes Association suggests that ANS testing is recommended for all patients with type two diabetes at time of diagnosis, and 5 years from time of diagnosis for patients with type one diabetes.
The American Heart Association recommends ABI testing for patients over the age of 50 with high risk of cardiovascular disease and all patients over the age of 70.
Other patients that are eligible for ANS testing include patients showing symptoms of Autonomic Neuropathy and Peripheral Artery Disease.
This constitutes roughly half of the American population.
It is important to note that individuals with diabetes that have autonomic neuropathy have a significantly higher risk of mortality, and higher hypoglycemia risk.